The 7th International Conference On Clinical and Engineering Frontiers in Pediatric and Congenital Heart Disease

第七届小儿和先天性心脏病临床和工程前沿国际会议

• 批准号: 9763076
• 负责人: Mark A Fogel
• 金额: $ 1.75万
• 依托单位: CHILDREN'S HOSP OF PHILADELPHIA
• 依托单位国家: 美国
• 财政年份: 2019
• 资助国家: 美国
• 起止时间: 2019-05-09 至 2020-05-08
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9763076
• 关键词: Adult; Award; Biomedical Engineering; Birth; Cause of Death; Childhood; Clinical; Clinical Engineering; Clinical Medicine; Collaborations; Communities; Congenital Abnormality; Country; Defect; Diagnostic; Discipline; Disease; Engineering; Faculty; Fostering; Funding; Goals; Individual; International; Mechanics; Medical; Medical Care Costs; Medicine; Minority Participation; Oral; Participant; Patients; Physicians; Population; Quality of life; Research; Research Personnel; STEM field; Scientist; Series; Societies; Source; Technology; Travel; Underrepresented Groups; Underrepresented Minority; Universities; Ursidae Family; Woman; age related; congenital heart disorder; doctoral student; frontier; graduate student; hemodynamics; improved; infant death; meetings; member; next generation; posters; programs; research and development; role model; symposium; tool; treatment planning

Project Summary and Abstract Congenital heart disease (CHD) is the leading cause of death for infants born with birth defects and represents 1% of births in the US. Successful treatment of CHD offers opportunities to improve quality of life for these individuals with consequent benefit to society. Over 1 million adults in the US are living with CHD. While there has been much progress with applying engineering fundamentals to understand and CHD over the past decades, there remains more to accomplish. To help focus engineers and physicians, the 6th International Conference on Clinical and Engineering Frontiers in Pediatric and Congenital Heart Disease, the meeting this project proposes, will bring together leading professionals in both engineering and medical disciplines to foster collaboration between the 2 communities in the study of treatment of CHD. Concurrently, the conference will serve as a platform to encourage the next generation of engineers and scientists to continue pursuing treatments for CHD. By bringing together these 2 groups, there is an opportunity to advance current treatment, identify under- researched defects and bring engineering to bear as an aid to physicians in understanding hemodynamic and mechanical aspects of the disease, improving and developing diagnostic tools and technology, and improving treatment planning. Therefore, a conference focused on CHD can achieve improved treatment and understanding of this age-related disease that afflicts a significant segment of the US population and the consequent reduction of medical costs associated with CHD accompanied by an improved patient quality of life. The conference will offer support to members of underrepresented groups involved in biomedical engineering research in pediatric and congenital heart disease, thus upholding the national goal of engaging underrepresented groups into the STEM disciplines. This conference also provides successful role models for women, 2 who are on the international organizing and steering committee, who have established vibrant research programs and labs in this field. This is the 6th iteration of this conference and we seek to maintain the continuity of the International Conference on Clinical and Engineering Frontiers in Pediatric and Congenital Heart Disease series that effectively brings together leading researchers in engineering and medicine who are engaged in cutting edge research in CHD. This is an excellent forum to exchange ideas and build of collaborations between leading researchers from around the world. Moreover, the conference promotes new researchers becoming engaged in the field through the Young Investigator podium speaker program and its young investigator poster competition. Our conference objective is to request support for the 6th in this series of international conferences on the engineering research in pediatric and congenital heart disease which has historically attracted both USA and international participants, affording an international forum for exchange of ideas and research.

项目概要和摘要 先天性心脏病（CHD）是先天缺陷婴儿死亡的主要原因， 在美国出生的1%。CHD的成功治疗为这些人提供了改善生活质量的机会 个人，从而造福社会。美国有超过100万成年人患有CHD。虽然 在过去的几十年里，应用工程基础知识来理解CHD已经取得了很大的进展， 还有更多的工作要做。为了帮助关注工程师和医生，第六届国际会议 儿科和先天性心脏病的临床和工程前沿，该项目提出的会议， 将汇集工程和医学学科的领先专业人士，促进合作 两个社区在冠心病治疗研究中的差异。同时，会议将作为一个 该平台旨在鼓励下一代工程师和科学家继续寻求冠心病的治疗方法。 通过将这两个群体聚集在一起，有机会推进目前的治疗，确定不足- 研究缺陷，并将工程学作为医生了解血流动力学的辅助手段， 机械方面的疾病，改善和发展诊断工具和技术， 治疗计划因此，关注CHD的会议可以改善治疗， 了解这种与年龄有关的疾病，影响了美国人口的一个重要部分， 从而降低与CHD相关的医疗费用，并改善患者的生活质量。 会议将为参与生物医学领域代表性不足的群体成员提供支持。 在儿科和先天性心脏病的工程研究，从而维护国家的目标， 将未被充分代表的群体纳入STEM学科。这次会议还为以下方面提供了成功的榜样： 国际组织和指导委员会中有2名妇女，她们建立了充满活力的 该领域的研究计划和实验室。 这是本次会议的第六次迭代，我们寻求保持国际的连续性， 儿科和先天性心脏病系列临床和工程前沿会议， 有效地汇集了领先的研究人员在工程和医学谁是从事尖端 CHD的研究这是一个很好的论坛，交流思想和建立合作之间的领导 来自世界各地的研究人员。此外，会议还促进新的研究人员参与 通过青年调查员讲台演讲者计划和青年调查员海报比赛。 我们的会议目标是请求支持这一系列国际会议中的第六次会议， 儿科和先天性心脏病的工程研究，历史上吸引了美国和美国 为交流思想和研究提供了一个国际论坛。